Hatton J, Holstad S G, Rosenbloom A D, Westrich T, Hirsch J
Division of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington.
Am J Hosp Pharm. 1991 Jul;48(7):1507-10.
The stability of nizatidine in total nutrient admixtures (TNAs) and the effect of the drug on the stability of lipid emulsions in the TNAs were studied. Duplicate 1476-mL amino acid-dextrose base solutions were prepared; nizatidine 300 mg was added to one. TNAs were prepared by adding to 75-mL samples of the base solutions Intralipid (KabiVitrum) or Liposyn II (Abbott) and sterile water as needed to achieve final lipid concentrations of 3% and 5%. Triplicate 100-mL samples for each lipid product and concentration were prepared; fat-free samples containing nizatidine were also studied. The theoretical final nizatidine concentration was 150 micrograms/mL. Samples were stored at 22 degrees C for 48 hours. Initially and at 12, 24, and 48 hours, the samples were visually inspected, tested for pH and particle-size distribution, and assayed by high-performance liquid chromatography for nizatidine concentration. No color change, precipitation, creaming, or oiling out was noted. For the 12 TNAs containing nizatidine, mean solution pH during the study was 5.88; stability of the lipid products requires pH values greater than or equal to 5.5. Particle-size distribution did not differ appreciably between the nizatidine-containing and drug-free TNAs. Nizatidine concentrations remained greater than 90% of the initial concentration. Nizatidine at a theoretical concentration of 150 micrograms/mL was stable for 48 hours at 22 degrees C in TNA solutions containing 3% and 5% Intralipid or Liposyn II and did not appear to affect lipid emulsion stability.
研究了尼扎替丁在全营养混合液(TNA)中的稳定性以及该药物对TNA中脂质乳剂稳定性的影响。制备了两份1476毫升的氨基酸 - 葡萄糖基础溶液;向其中一份加入300毫克尼扎替丁。通过向75毫升基础溶液样品中加入英脱利匹特(卡比维特伦)或力保肪宁II(雅培)以及必要时加入无菌水来制备TNA,以使最终脂质浓度达到3%和5%。针对每种脂质产品及其浓度制备三份100毫升样品;还研究了含尼扎替丁的无脂样品。理论上最终尼扎替丁浓度为150微克/毫升。样品在22℃下储存48小时。在初始时刻以及12、24和48小时时,对样品进行外观检查、pH值和粒度分布测试,并通过高效液相色谱法测定尼扎替丁浓度。未观察到颜色变化、沉淀、乳析或油相分离现象。对于12份含尼扎替丁的TNA,研究期间溶液的平均pH值为5.88;脂质产品的稳定性要求pH值大于或等于5.5。含尼扎替丁的TNA和不含药物的TNA之间的粒度分布没有明显差异。尼扎替丁浓度保持在初始浓度的90%以上。理论浓度为150微克/毫升的尼扎替丁在含有3%和5%英脱利匹特或力保肪宁II的TNA溶液中于22℃下稳定48小时,并且似乎不影响脂质乳剂的稳定性。